| Active ingredients | Status | Update | Specialty |
| methylphenidate | Supply tension | 19/12/2025 | Quasym LP, modified-release capsule |
| fluorouracil | Supply tension | 19/12/2025 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| medroxyprogesterone | Supply tension | 18/12/2025 | Depo Prodasone 500 mg, injectable suspension |
| ifosfamide | Supply tension | 18/12/2025 | Holoxan 1000 mg powder for solution for injection and 2000 mg powder for parenteral use |
| synthetic vitamin A concentrate, oil form | Marketing discontinuation | 17/12/2025 | Vitamin A Dulcis 25,000 IU per 100 g, ophthalmic ointment – (imported from Vitamin A Blache) |
| ondansetron | Supply tension | 17/12/2025 | Zophren 2 mg/mL, injectable solution in ampoule (IV) |
| trandolapril | Supply tension | 17/12/2025 | Trandolapril 2 mg and 4 mg |
| trandolapril | Return to availability | 17/12/2025 | Trandolapril 0.5 mg, capsules |
| venlafaxine | Supply tension | 17/12/2025 | Specialties based on Venlafaxine LP 37.5 mg and LP 75 mg in extended-release capsules |
| diltiazem (hydrochloride) | Supply tension | 17/12/2025 | Tildiem 25 mg, powder and solution for intravenous injection |
| amphotericin B | Return to availability | 15/12/2025 | Fungizone 10%, oral suspension |
| venlafaxine | Return to availability | 15/12/2025 | Venlafaxine Viatris 50 mg, film-coated tablet |
| digoxin | Return to availability | 15/12/2025 | Digoxin Nativelle 5 µg/0.1 ml, oral solution in drops |
2025年12月22日